Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: Implications for the risk of plaque rupture

Heart

Volumn 84, Issue 4, 2000, Pages 377-382

  Williams, M J A ^a   Low, C J S ^a   Wilkins, G T ^a   Stewart, R A H ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Calcium channel antagonists; Coronary disease; Mechanics; Blockers

Indexed keywords

ESMOLOL; NICARDIPINE;

ADULT; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTERY TONE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033798804     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.4.377     Document Type: Article

References (34)

1. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Card Dis 1985;27:335-71.
2. Dargie HJ, Ford I, Fox KM, for the TIBET study group. Total ischaemic burden European trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 1996;17:104-12.
3. Braun S, Boyko V, Behar S, et al. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol 1996;28:7-11.
4. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
5. Furberg CD, Psaty BM. Corrections to the nifedipine meta-analysis. Circulation 1996;93:1475-6.
6. Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS): a randomized controlled trial. JAMA 1996;276:785-91.
7. Waters D. Proischemic complications of dihydropyridine calcium channel blockers. Circulation 1991;84:2598-600.
8. Packer M. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 1989; 80(suppl IV):IV59-67.
9. Falk E. Why do plaques rupture? Circulation 1992;86(suppl III):III30-42.
10. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
11. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;ii:941-4.
12. Potkin BN, Bartorelli AL, Gessert JM, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 1990;81:1575-85.
13. Williams MJ, Stewart RA, Low CJ, et al. Assessment of the mechanical properties of coronary arteries using intravascular ultrasound: an in vivo study. Int J Card Imaging 1999; 15:287-94.
14. Carew TE, Vaishnav RN, Patel DJ. Compressibility of the arterial wall. Circ Res 1968;23:61-8.
15. Dobrin PB, Rovick AA. Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. Am J Physiol 1969;217:1644-51.
16. Langewouters GJ, Wesseling KH, Goedhard WJ. The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model. J Biomech 1984;17:425-35.
17. Kaufmann P, Vassalli G, Utzinger U, et al. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol 1995;26:624-31.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
19. Estacio RO, Jeffers BW, Hiatt WR, et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-52.
20. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-5.
21. Alderman MH, Cohen H, Roque R, et al. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997;349:594-8.
22. Grossman E, Messerli FH. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am J Cardiol 1997;80:1453-8.
23. Popov EP. Mechanics of materials, 2nd ed. Englewood Cliffs: Prentice-Hall, 1976.
24. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57(suppl F):43-9F.
25. Yusuf S. Verapamil following uncomplicated myocardial infarction: promising, but not proven. Am J Cardiol 1996;77:421-2.
26. Hess OM, Bortone A, Gaglione A, et al. Effect of intracoronary and intravenous propranolol on human coronary arteries. Eur Heart J 1989;10:153-8.
27. Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med 1993;329:1677-83.
28. Willich SN, Lewis M, Lowel H, et al. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med 1993; 329:1684-90.
29. Arbab-Zadeh A, Penny WF, DeMaria AN, et al. Prevalence and extent of axial movement of intracoronary ultrasound transducer during the cardiac cycle [abstract]. Circulation 1996;94(suppl I):I-78.
30. Loree HM, Kamm RD, Stringfellow RG, et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992;71:850-8.
31. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 1993;87:1179-87.
32. Loree HM, Tobias BJ, Gibson LJ, etl al. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb 1994;14:230-4.
33. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
34. Lee RT, Loree HM, Fishbein MC. High stress regions in saphenous vein bypass graft atherosclerotic lesions. J Am Coll Cardiol 1994;24:1639-44.